erythrokinetics

Translation of potential therapies in the diverse hemoglobinopathy population is likely affected by underlying molecular mutations, genetic modifier traits[42 –50 ], and by physiologic factors such as erythrokinetics and endogenous erythropoeitin levels[6 ].

2015 December 30, “Novel Inducers of Fetal Globin Identified through High Throughput Screening (HTS) Are Active In Vivo in Anemic Baboons and Transgenic Mice”, in PLOS ONE, →DOI